Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Case Number
Disposition
Judges
Acts
  • Central Excise Tariff Act, 1985
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Case Number
Disposition
Judges
Acts
  • Central Excise Tariff Act, 1985
Smart Summary

Factual and Procedural Background

This appeal concerns the classification for excise tariff purposes of the appellant’s product, “Amrutanjan Pain Balm Ayurvedic.” The appellant sought classification as an Ayurvedic medicament under tariff heading 3003.30 of the Central Excise Tariff Act, 1985, which would attract a nil rate of duty. The excise authorities and the Customs, Excise and Gold (Control) Appellate Tribunal rejected the appellant’s claim and upheld classification on the basis that the product was not Ayurvedic.

Legal Issues Presented

  1. Whether “Amrutanjan Pain Balm Ayurvedic” was an Ayurvedic medicament classifiable under tariff heading 3003.30 of the Central Excise Tariff Act, 1985 (nil rate of duty).

Arguments of the Parties

The opinion does not contain a detailed account of the parties' legal arguments.

Table of Precedents Cited

No precedents were cited in the provided opinion.

Court's Reasoning and Analysis

The Tribunal had treated the balm as non-Ayurvedic because its main ingredients (Menthol IP, Camphor IP, Turpentine IP, and Methyl Salicylate IP) were considered “synthetic” and because, in its view, Ayurvedic science recognises only natural extracts from medicinal plants that cannot be substituted by modern chemical ingredients. It also inferred an intent to evade excise duty based on alleged changes in naming on invoices and labels from IP chemical names to Ayurvedic nomenclatures.

The Court found that the Tribunal overlooked that the same article may be used both in Ayurveda and in Western sciences and may be known by different names. It explained that the “IP” designation only indicates pharmaceutical quality, appropriate for use in a medicinal preparation. The Court held that the Tribunal erred in treating the listed ingredients as synthetic in nature. On the evidence, the Court was inclined to hold that these were articles known to both Ayurvedic and Western sciences and refined for use in medicaments. Because the ingredients were known to Ayurveda, their use in the balm did not, by itself, make the balm a non-Ayurvedic product.

Holding and Implications

ALLOWED; ORDER SET ASIDE; CLASSIFICATION AS AYURVEDIC MEDICINE GRANTED.

The judgment of the Tribunal was set aside, and the appellant’s balm was held to be an Ayurvedic medicine entitled to be classified as such under the claimed tariff heading, with the direct effect that it would be treated as eligible for the nil rate of duty associated with that classification. The opinion does not discuss broader implications or state that it sets any new precedent.

    Amrutanjan Ltd. v. Collector Of Central Excise .

    Order

    1. We are concerned in this appeal against the decision of the Customs, Excise and Gold (Control) Appellate Tribunal only with the appellant's product known as “Amrutanjan Pain Balm Ayurvedic”. The appellant sought classification of the same on the basis that it was an Ayurvedic medicament under tariff heading 3003.30 of the Central Excise Tariff Act, 1985 and attracted nil rate of duty. The authorities below as also the Tribunal did not accept this classification. The Tribunal, in the order under appeal, upheld the contention of the Excise authorities that the balm was not an Ayurvedic medicine because its main ingredients were Menthol IP, Camphor IP, Turpentine IP and Methyl Salicylate IP, which were of a synthetic nature. The contention of the appellant that the same ingredients had an Ayurvedic nomenclature as could be found in authoritative text-books was rejected because, according to the Tribunal, Ayurvedic science recognises only the use of natural extracts from medicinal plants and these could not be substituted by modern chemical ingredients. The Tribunal said that the appellant had imported synthetic grade IP chemicals and had, with the intention of evading liability to excise duty, asked the suppliers to change the names upon invoices and labels to Ayurvedic nomenclatures. Thus, methyl salicylate was changed to “pudina ka phool”, dementholised oil to “pudina ka tel”, thymol and turpentine to “ajwan ka phool” and “turpentine ka tel” and methyl salicylate to “winter green tel”. The Tribunal would appear to have overlooked the fact that the same article can have a use both in Ayurveda and in the western sciences and be known by different names. The letters IP after the article concerned only demonstrate that it is of pharmaceutical quality, as it ought to be if it is to be used in a medicinal preparation. The Tribunal was in error in considering that the articles aforestated were synthetic in nature. Having regard to the evidence, we are inclined to hold that the articles afore-mentioned were articles known both to Ayurvedic and western sciences and were refined for use in medicaments. Since they were known to Ayurveda, their use in the making of the balm did not, by itself, make the balm a non-Ayurvedic product.

    2. Accordingly, the appeals are allowed. The judgment under appeal is set aside. It is held that the appellants' balm is an Ayurvedic medicine entitled to be classified as such.

    Use AI to get other relevant cases.

    Comments

    Amrutanjan Ltd. v. Collector Of Central Excise .
    (Mar 30, 1995)